Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04541563 · ClinicalTrials.gov registry record · NA

Fisher Wallace Neurostimulation & Depression Study

A NA study of Major Depressive Disorder, sponsored by ProofPilot.

Active
Registry status
NA
Development phase
175
Enrollment target
1
Study location

NCT04541563 is a NA study of Major Depressive Disorder that is active but no longer recruiting, run by ProofPilot. The registered enrollment target is 175 participants, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04541563, a NA study of Major Depressive Disorder, is active but no longer recruiting, sponsored by ProofPilot.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
175 participants
Enrollment target
1
Study location

Study Summary

Examine the safety and effectiveness of the Fisher Wallace Cranial Electrotherapy Stimulator Device on Major Depressive Disorder using two 20-minute per day treatment sessions over eight weeks.

Conditions Studied

Interventions

  • DEVICE Fisher Wallace Cranial Electrotherapy Stimulator Device

Study Locations (1)

New York

  • ProofPilot (Remote Virtual Trial) - New York

Trial Details

FieldValue
Enrollment Target 175 participants
Start Date 2020-08-24
Est. Completion 2021-11-30
Phase NA

Sponsor

ProofPilot

7 total trials

What the Registry Record Tells You About NCT04541563

The ClinicalTrials.gov registry entry for NCT04541563 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (53% lower). The listed sponsor is ProofPilot, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 1 intervention - of which Fisher Wallace Cranial Electrotherapy Stimulator Device is the first listed.

NCT04541563 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04541563 about?

NCT04541563 is a clinical study titled "Fisher Wallace Neurostimulation & Depression Study". Examine the safety and effectiveness of the Fisher Wallace Cranial Electrotherapy Stimulator Device on Major Depressive Disorder using two 20-minute per day treatment sessions over eight weeks.

What is the current status of trial NCT04541563?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 175 participants. The study started on 2020-08-24. Estimated completion is 2021-11-30.

What conditions does trial NCT04541563 study?

This clinical trial studies the following conditions: Major Depressive Disorder.

What interventions are being tested in trial NCT04541563?

The interventions under investigation include: Fisher Wallace Cranial Electrotherapy Stimulator Device (DEVICE).

Who is sponsoring clinical trial NCT04541563?

This trial is sponsored by ProofPilot, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04541563 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.